HIM
CMD

Hillsdale Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Hillsdale Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-50
Closed -$5K – 573
2018
Q2 		$5K Sell
50
-10
-17% -$1.12K ﹤0.01% 425
2018
Q1 		$7K Buy
+60
New +$6.72K ﹤0.01% 373

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hillsdale Investment Management's CMD Position: Q3 2018 in Review

Hillsdale Investment Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 50 shares — an estimated $5K sold.

Hillsdale Investment Management first reported a position in CMD in Q1 2018 and held it in 2 quarters. The position peaked at $7K in Q1 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Hillsdale Investment Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Hillsdale Investment Management sold 50 Cantel Medical Corporation shares in Q3 2018, an estimated $5K.
  • Hillsdale Investment Management first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 2 quarters.
  • Hillsdale Investment Management's Cantel Medical Corporation position peaked at $7K in Q1 2018.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Hillsdale Investment Management's 13F filing for Q3 2018, filed 9 Nov 2018.